Antibacterial prophylaxis of febrile neutropenia is not effective in the pre‐engraftment period in pediatric allogeneic hematopoietic stem cell transplantation
- 23 May 2020
- journal article
- letter
- Published by Wiley in Transplant Infectious Disease
- Vol. 22 (5) , e13340
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research ConsortiumClinical Infectious Diseases, 2019
- Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell TransplantationClinical Infectious Diseases, 2019
- Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell TransplantationJAMA, 2018
- A Prospective Study on the Epidemiology of Febrile Episodes during Chemotherapy-Induced Neutropenia in Children with Cancer or after Hemopoietic Stem Cell TransplantationClinical Infectious Diseases, 2007
- A multicenter, randomized, double blind placebo-controlled trial of amoxicillin/clavulanate for the prophylaxis of fever and infection in neutropenic children with cancerThe Pediatric Infectious Disease Journal, 2003